A Study of Safety and efficacy of anticoagulant therapy in the treatment of Atrial Fibrillation in KANAGAWA

A Study of Safety and efficacy of anticoagulant therapy in the treatment of Atrial Fibrillation in KANAGAWA - ASSAF-K

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011830

Enrollment

5000

Registered

2013-09-21

Start date

2013-07-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with any type of atrial fibrillation

Exclusion criteria

Exclusion criteria: Inappropriate patients considered by attending physicians

Design outcomes

Primary

Measure	Time frame
1. clinical profiles of the patients 2. clinical status of treatments 3. outcome 3-1 survive or died and its cause (cardiac or cerebro-vascular, others) 3-2 cerebro-vascular events (cerebral infarction, intra-cranial bleeding, sequela: symptomatic or transient) 3-3 bleeding (Major or others) Major bleeding defined by the criteria of International Society on Thrombosis and Haemostasis.	—

Secondary

Measure	Time frame
1. Relationship between efficacy/safety and treatments 2. comparison between pharmacological treatments regarding outcome	—

Countries

Japan

Contacts

Public ContactYutaka Hatori

Hatori Clinic Internal Medicine

yutaka@hatori.or.jp044-522-0033

Outcome results